A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease
Clinical trial NCT07187440 · RECRUITING
Trial details
- NCT number
- NCT07187440
- Sponsor
- Takeda
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-11-01
- Primary completion
- 2028-11-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.